JD.com Prices Upsized Offering of US$1.75 Billion Convertible Senior Notes
BEIJING, May 21, 2024 (GLOBE NEWSWIRE) — JD.com, Inc. (“JD” or the “Company”) (NASDAQ: JD and HKEX: 9618 (HKD counter) […]
Merit Medical Launches basixSKY™ Inflation Device
SOUTH JORDAN, Utah, May 21, 2024 (GLOBE NEWSWIRE) — Merit Medical Systems, Inc. (NASDAQ: MMSI), a global leader of healthcare […]
Rail Vision Received Notice of Allowance for US Patent on AI-Powered Railway Obstacle Detection System
Ra’anana, Israel, May 21, 2024 (GLOBE NEWSWIRE) — Rail Vision Ltd. (Nasdaq: RVSN) (the “Company”), a technology company at the […]
Verisk Analytics, Inc. Announces Tender Offer for up to $400 million Principal Amount of Outstanding Debt
JERSEY CITY, N.J., May 21, 2024 (GLOBE NEWSWIRE) — Verisk Analytics, Inc. (Nasdaq: VRSK) (“Verisk” or the “Company”), a leading […]
GT Biopharma, Inc. Announces $3.2 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
BRISBANE, CALIFORNIA, May 21, 2024 (GLOBE NEWSWIRE) — GT Biopharma, Inc. (NASDAQ: GTBP) (the “Company”), today announced that it has […]
Invidia Capital Management Announces Healthcare Investment Firm Launch with Strategic Investment from GCM Grosvenor
NEW YORK and CHICAGO, May 21, 2024 (GLOBE NEWSWIRE) — Invidia Capital Management, a healthcare investment firm founded by former […]
Lyra Therapeutics Announces Cost-Cutting Measures to Preserve Capital
WATERTOWN, Mass., May 21, 2024 (GLOBE NEWSWIRE) — Lyra Therapeutics, Inc. (Nasdaq: LYRA) (“Lyra” or the “Company”), today announced that […]
Micron Expands Workforce Development Collaborations to Meet Future Semiconductor Job Demand
BOISE, Idaho, May 21, 2024 (GLOBE NEWSWIRE) — Micron Technology, Inc. (Nasdaq: MU), one of the world’s largest semiconductor companies […]
Sana Biotechnology Highlights Publication in Nature Biotechnology of Novel In Vivo Preclinical Data Showing the Potential for Pluripotent Stem Cell-Derived Human Glial Progenitor Cell Transplantation as a Treatment for Huntington’s Disease and Other Glial-based Neurodegenerative Conditions
Healthy transplanted human glial cells replaced diseased glial cells in the brains of human glial chimeric Huntingtin mice Additional proof-of-concept […]
FDA Clears Cingulate to File for Marketing Approval of CTx-1301 in the Treatment of ADHD
Phase 3 Data Collected to Date Sufficient for Submission of New Drug Application CTx-1301 Could Benefit >60% of ADHD […]
